Journal List > Korean J Gastroenterol > v.76(1) > 1145227

Endoscopic and Endosonographic Features of Histologically Proven Gastric Ectopic Pancreas by Endoscopic Resection

Abstract

Background/Aims

Distinguishing gastric ectopic pancreas (GEP) from malignant tumors is relatively difficult. This study evaluated the endosonography findings of pathologically proven GEP.

Methods

Thirty-one patients diagnosed with GEP based on a histopathological analysis from January 2004 to July 2018 were enrolled in this study. All patients underwent EUS and an endoscopic resection.

Results

Seventeen patients were female, and the median age was 41.1 years (range, 14-74). The lesions were localized most commonly in the antrum. The mean size of the GEP was 10.6 mm (range, 7-15). Superficial type lesions, lesions with heterogeneous echogenicity, mixed pattern lesions, and lesions with indistinct borders were commonly observed on EUS. Calcification, anechoic duct-like structures, and thickening of the muscularis propria were observed in some patients. Endoscopic mucosal resection (41.9%) and endoscopic submucosal dissection (58.1%) were performed. The mean procedure time was 22.5 minutes. Complete resection was achieved for 71% of patients. No statistically significant results between the endosonography findings and complete resection rates were obtained. The mean follow-up esophagogastroduodenoscopy duration was 4.5 months. None of the patients presented with residual lesions on subsequent endoscopy.

Conclusions

EUS can help identify the features of GEP. Careful observations of the EUS findings can avoid unnecessary removal of GEP.

INTRODUCTION

Ectopic pancreas, which is also known as heterotopic pancreas and accessory pancreas, refers to ectopic pancreatic tissue found frequently in the distal stomach, duodenum, or proximal jejunum and within the Meckel’s diverticulum, gallbladder, bile ducts, and minor and major papillae.1 Although most patients with ectopic pancreas are asymptomatic, rare complications have been reported, such as upper gastrointestinal bleeding, gastric outlet obstruction, obstructive jaundice, intestinal obstruction, intussusception, and malignant transformation.2,3 The typical endoscopic findings include a firm round or oval subepithelial lesion (SEL) with central dimpling or umbilication.4,5 EUS provides useful information regarding the location, size, and echogenicity of a tumor. On the other hand, it is difficult to differentiate between ectopic pancreas and other SELs, particularly gastrointestinal stromal tumors, which have malignant potential.6 Therefore, a histological diagnosis is required in some cases. As a diagnosis is usually difficult with specimens obtained using standard biopsy forceps, endoscopic techniques, including endoscopic mucosal resection (EMR), endoscopic submucosal dissection (ESD), and EUS-guided tissue sampling, have been developed to obtain tissue samples.7-9 Sometimes, it is difficult to achieve a complete resection by EMR or ESD due to probable noninflammatory adhesion, which can occur during embryonic development, as explained by the aberrant primordium theory.10 This study examined the EUS characteristics of gastric ectopic pancreas (GEP) confirmed by histological analysis of the specimens obtained by an endoscopic resection.

SUBJECTS AND METHODS

1. Patients and study protocol

A total of 6,143 patients who underwent EUS for an evaluation of gastric SELs between January 2004 and July 2018 at Chonnam National University Hospital were identified retrospectively. Of these, 182 patients underwent an endoscopic resection. Finally, 31 patients with histologically confirmed GEP were identified. These patients underwent EUS before the endoscopic resection (Fig. 1).

2. Endoscopic and EUS findings

A EUS probe (UM-2R; Olympus, Tokyo, Japan) and probe driving unit (MAJ-935; Olympus) were initially used to map the lesions. The imaging frequency of the probe was 12 MHz. EUS was performed by an experienced endosonographer (J.S.R.). All examinations were performed under intravenous sedation using midazolam and propofol. The lesion was scanned after filling the stomach with deaerated water.
DH Kim and HS Lee recorded and reviewed the following EUS features for all lesions: 1) location, 2) gross shape (Yamada classification11), 3) presence of central dimpling or umbilication on the surface, 4) maximal diameter, 5) layer of origin, 6) echogenicity (hypoechoic, hyperechoic or mixed), 7) homogeneity (homogeneous or heterogeneous), 8) distinctness of the border (distinct or indistinct), 9) presence of anechoic duct-like structures, 10) presence of hyperechoic foci with acoustic shadowing (suggestive calcification), and 11) muscularis propria (PM; fourth layer) thickening (PM layer thickening was compared with normal PM layer thickening [PMep/PMnormal]). Ectopic pancreas was classified as the superficial type (S-type) and deep type (D-type) based on the classification proposed by Park et al.4 In the S-type, the lesion originated in the second or third layer. In the D-type, the lesion was in the third and fourth layers with or without extension into the fifth layer. Moreover, PM thickening was defined as “PMep/PMnormal ≥2” (Fig. 2).

3. Endoscopic resection

Endoscopic resection was performed using two methods: EMR and ESD. EMR was performed using the injection-and-snaring technique. First, a saline injection with a small amount of epinephrine (0.025 mg/mL) and indigo carmine was used to lift the lesion. The lesion was then elevated by retraction using grasping forceps (FD-410LR; Olympus) that was passed through a polypectomy snare loop (SD-5L-1; Olympus). After snaring, the lesion was resected. ESD was performed by injection and dissection of the tumor. In ESD, the margins of the lesion were marked using the tip knife, and a submucosal injection of saline with a small amount of epinephrine and indigo carmine lifted the lesion. An initial circumferential incision was then made around the lesion, and the lesion was dissected using an electrosurgical knife (Dual Knife [KD-650L]; Olympus).

4. Definition

1) The procedure time was defined as the time from the first marking or the first injection to the achievement of hemostasis. 2) An en bloc resection was defined as a resection wherein the tumor was resected as a single piece. 3) Complete resection was defined as a resection wherein the tumor was removed in one piece (en bloc resection), and the horizontal/vertical margin was histologically free from the tumorous glands. And 4) adverse events were defined as complications, such as bleeding, perforation, or aspiration pneumonia, associated with the endoscopic resection.

5. Statistical analysis

Statistical analyses were performed using SPSS version 23.0 (SPSS Inc., IBM, Chicago, IL, USA). The continuous data are presented as the mean±standard deviation or medians (ranges), and the categorical data are expressed as the absolute and relative frequencies. The continuous variables were analyzed using a Student’s t-test. The categorical data were examined using a Fisher’s exact test or chi-square test with a Yates’s correction.

6. Ethical considerations

The present study was conducted in accordance with the ethical guidelines of the Declaration of Helsinki. The Institutional review board of Chonnam National University Hospital approved this study (IRB No., CNUH-2018-199).

RESULTS

1. Baseline characteristics of the lesions

Thirty-one patients were enrolled in this study (Table 1). An endoscopic resection was performed under the following conditions: 1) presence of symptoms (6.5%, 2/31; one patient with indigestion and one patient with intermittent abdominal pain); 2) lesions suspected to be malignant based on the endoscopy and EUS findings (38.7%, 12/31; four patients with neuroendocrine tumors, two patients with adenocarcinomas, and six patients with gastrointestinal stromal tumors; 3) patients who wanted to undergo a resection (54.8%, 17/31).
Seventeen patients (54.8%) were female, and the median age was 41.1 years (range, 14-74). The lesions were localized most commonly in the antrum (n=26, 83.9%). Five lesions (16.1%) were located in the corpus.
The mean size of the lesions was 10.6 mm (7.0-15.0). With respect to the gross shape based on the endoscopic findings, 12 (38.7%) lesions were classified as Yamada Type I and 19 (61.3%) lesions as Yamada Type II. Fifteen patients (48.4%) had central dimpling in the endoscopic gross findings. Twenty-two patients (71.0%) had S-type lesions and nine patients (29.0%) had D-type lesions. Seven lesions (22.6%) were homogeneous, and 24 lesions (77.4%) were heterogeneous. Nineteen lesions (61.3%) exhibited mixed echogenicity, and seven lesions (22.6%) exhibited hypoechoic echogenicity. The borders were distinct in 14 lesions (45.2%) and indistinct in 17 lesions (54.8%). Four patients (12.9%) presented with calcification, and 10 patients (32.3%) presented with an anechoic duct-like structure on EUS. The mean PMep/PMnormal was 2.46 (range, 0.77-5.8), and PM thickening was observed in 13 patients (41.9%) (Table 2).

2. Clinical outcomes of endoscopic resection

Of the 31 patients, 13 patients (41.9%) underwent EMR, and 18 patients (58.1%) underwent ESD. The mean procedure time was 22.5 minutes (range, 5-48). En bloc resection was achieved in 27 patients (87.1%), and a complete resection was achieved in 22 patients (71%). Immediate bleeding (n=5, 16.1%) and muscle defects (n=3, 9.7%) were observed, and all such complications were treated using an endoclip. No serious adverse events, such as perforations, were observed. Follow-up esophagogastroduodenoscopy was performed on 19 patients (61.2%). The mean duration of follow- up esophagogastroduodenoscopy was 4.5 months (range, 1-18) after the endoscopic resection; none of the patients presented with residual lesions on subsequent endoscopy (Table 3, Fig. 3).

3. Outcomes of endoscopic resection according to the EUS findings of the tumor

This study analyzed the relationship between the EUS findings and the complete resection rate, including echogenicity, homogeneity, distinctness of the border, presence of anechoic duct-like structure or hyperechoic foci, PM thickening, and type of GEP. On the other hand, there was no significant correlation between the EUS findings and the complete resection rate.

DISCUSSION

In this study, Yamada type II lesions and central dimpling were the common gross endoscopic findings for GEP. The lesions were most commonly located in the antrum. The common EUS findings for GEP were mixed echogenicity, heterogeneous homogeneity, absence of calcification, and indistinct borders.
Although the typical endoscopic findings showed a submucosal nodule with central umbilication that corresponded to a draining duct, GEP has several endoscopic findings that can be confused with other SELs with malignant potential. Central dimpling, a characteristic endoscopic finding of GEP, was noted in 48.4% of the patients, which was similar to the results of previous studies.4,12
The EUS findings of GEP are extremely diverse, and the inter-observer agreement was poor13,14 because of the varying incidence of different pathological types of GEP.14 The histological structure is similar to that of normal pancreatic tissue. Matsushita et al.15 suggested the EUS findings of GEP with histological comparisons. An indistinct border was related to the lobular structure of the acinus tissue at the margin. The observed heterogeneous internal echo patterns were due mainly to hypoechoic acinus tissue accompanied by scattered small hyperechoic areas related to the adipose tissue content. A distinct margin and more hypoechoic features are related to the dense acinus tissue located predominantly in the PM. The anechoic echogenicity of GEP was associated with ductal dilatation of the pancreatic tissue. The thickening in the fourth layer was related to the hypertrophy of the PM.
Hase et al.16 initially proposed a classification of the EUS findings of GEP. M-type lesions include lesions involving the PM layer. In the S-type, however, the ectopic pancreatic tissue is located in the submucosal and mucosal layers without involvement of the muscle layer. Park et al.4 modified Hase’s classification such that the lesions were classified as the S-type and D-type. In the present study, D-type GEP was observed in 29% of patients. This finding was inconsistent with those of Park’s study,4 because patients eligible for endoscopic resection were included. While S-type lesions are usually small and found in the antrum, D-type lesions are large and found in the gastric body.17 In the present study, among nine patients with D-type lesions, seven lesions were relatively small (<15 mm in diameter) and located in the antrum. Sometimes, it may be difficult to diagnose D-type GEP because it appears as a heterogeneously hypoechoic mass involving the third and fourth layers on EUS such that it may be misdiagnosed as a gastrointestinal stromal tumor. Therefore, understanding and recognizing the common EUS findings of GEP and adequate tissue sampling may help avoid unnecessary surgery. The pathological diagnosis of GEP using conventional biopsy forceps is usually difficult because of the limitation of approaching deep specimens. Therefore, clinicians must decide whether endoscopic procedures, such as an endoscopic resection and EUS-guided intervention for tissue sampling, should be performed.6,15,18-21 Endoscopic resection is a useful tool for the tissue sampling of gastric SELs,7,12,22 particularly S-type lesions.
In some cases, however, it is difficult to achieve a complete resection because of noninflammatory adhesion to the deep layer, as explained by the aberrant primordium theory, in which during embryonic development, partial primordial pancreatic tissue forms noninflammatory adhesion with the adjacent gastric and intestinal wall and mesentery.10 PM layer thickening is commonly observed in GEP. Even if the lesion does not show PM layer involvement, lesions with PM thickening are not subjected to a complete resection due to adhesion by pancreatic juice; therefore, the researchers analyzed this further. The expectation was that the complete ablation rate would decrease with PM thickening, but the results were different. Although the PM thickening area has adhesion by pancreatic juice, this adhesive tissue does not appear to interfere with the endoscopic resection through fibrotic changes.
An attempt was made to evaluate the EUS findings as predictors for a complete resection of GEP in this study. On the other hand, none of the EUS findings, such as border distinctness, presence of homogeneous echogenicity, and PM thickening, were significantly associated with a complete resection. Moreover, no residual lesions were detected in the follow-up despite the incomplete resection. Owing to the electrocautery effect of endoscopic ablation, the residual tissue may not have been observed even if complete ablation was not possible. Moreover, it is also possible that the recurrence could not be confirmed because of the relatively short follow- up period. As an ectopic pancreas is often asymptomatic and located in the subepithelium, follow-up endoscopy may not be a useful method to confirm the recurrence of an ectopic pancreas. In addition, even if it was not resected completely, no remaining tissue was observed, meaning that a complete resection may be unnecessary. Rather, before performing the endoscopic resection, it is better not to perform the endoscopic resection if the EUS findings have been accurately analyzed and judged to be suitable for the GEP.
This study had several limitations. A single-center study with a retrospective design based on observational data was conducted. Therefore, there were limitations in analyzing the EUS findings of GEP located in the deep layer and obtaining information regarding the diagnostic accuracy of the EUS findings. In addition, selection bias may be present because only the histological findings of GEP were confirmed and analyzed on the endoscopic resection. The difficulty in performing procedures, such as an endoscopic resection, may have been underestimated. Moreover, in cases of typical GEP, endoscopic removal was not performed. Nevertheless, these findings provide an impetus for future prospective studies with an accurate methodological design on endoscopic resection with respect to the diagnosis of GEP based on the EUS findings. EUS can help identify the features of GEP. Unnecessary removal of GEP can be avoided with careful observations of the EUS findings.

Notes

Financial support: This research was supported by the Chonnam National University Hospital Research Institute of Clinical Medicine (BCRI 20004).

Conflict of interest: None.

REFERENCES

1. Lucena JF, Alvarez OA, Gross GW. 1997; Endoscopic resection of heterotopic pancreas of the minor duodenal papilla: case report and review of the literature. Gastrointest Endosc. 46:69–72. DOI: 10.1016/S0016-5107(97)70214-1. PMID: 9260710.
crossref
2. Slidell MB, Schmidt EF, Jha RC, et al. 2009; Solid pseudopapillary tumor in a pancreatic rest of the jejunum. J Pediatr Surg. 44:E25–E27. DOI: 10.1016/j.jpedsurg.2009.01.074. PMID: 19361620.
crossref
3. Lemaire J, Delaunoit T, Molle G. 2014; Adenocarcinoma arising in gastric heterotopic pancreas. Case report and review of the literature. Acta Chir Belg. 114:79–81. DOI: 10.1080/00015458.2014.11680983. PMID: 24720145.
crossref
4. Park SH, Kim GH, Park DY, et al. 2011; Endosonographic findings of gastric ectopic pancreas: a single center experience. J Gastroenterol Hepatol. 26:1441–1446. DOI: 10.1111/j.1440-1746.2011.06764.x. PMID: 21557771.
crossref
5. Yüksel M, Kacar S, Akpinar MY, et al. 2017; Endosonogragphic features of lesions suggesting gastricectopic pancreas: experience of a single tertiary center. Turk J Med Sci. 47:313–317. DOI: 10.3906/sag-1602-181. PMID: 28263508.
crossref
6. Kim JH, Lim JS, Lee YC, et al. 2008; Endosonographic features of gastric ectopic pancreases distinguishable from mesenchymal tumors. J Gastroenterol Hepatol. 23:e301–e307. DOI: 10.1111/j.1440-1746.2008.05351.x. PMID: 18522684.
crossref
7. Ryu DY, Kim GH, Park DY, et al. 2010; Endoscopic removal of gastric ectopic pancreas: an initial experience with endoscopic submucosal dissection. World J Gastroenterol. 16:4589–4593. DOI: 10.3748/wjg.v16.i36.4589. PMID: 20857531. PMCID: PMC2945492.
crossref
8. Shim CS, Jung IS. 2005; Endoscopic removal of submucosal tumors:preprocedure diagnosis, technical options, and results. Endoscopy. 37:646–654. DOI: 10.1055/s-2005-861477. PMID: 16010609.
9. Attwell A, Sams S, Fukami N. 2015; Diagnosis of ectopic pancreas by endoscopic ultrasound with fine-needle aspiration. World J Gastroenterol. 21:2367–2373. DOI: 10.3748/wjg.v21.i8.2367. PMID: 25741143. PMCID: PMC4342912.
crossref
10. Hebrok M, Kim SK, St Jacques B, McMahon AP, Melton DA. 2000; Regulation of pancreas development by hedgehog signaling. Development. 127:4905–4913. PMID: 11044404.
crossref
11. Yamada T, Ichikawa H. 1974; X-ray diagnosis of elevated lesions of the stomach. Radiology. 110:79–83. DOI: 10.1148/110.1.79. PMID: 4808543.
crossref
12. Chou JW, Cheng KS, Ting CF, et al. 2014; Endosonographic features of histologically proven gastric ectopic pancreas. Gastroenterol Res Pract. 2014:160601. DOI: 10.1155/2014/160601. PMID: 25371670. PMCID: PMC4209789.
crossref
13. Gress F, Schmitt C, Savides T, et al. 2001; Interobserver agreement for EUS in the evaluation and diagnosis of submucosal masses. Gastrointest Endosc. 53:71–76. DOI: 10.1067/mge.2001.111384. PMID: 11154492.
crossref
14. Gottschalk U, Dietrich CF, Jenssen C. 2018; Ectopic pancreas in the upper gastrointestinal tract: is endosonographic diagnosis reliable? Data from the German Endoscopic Ultrasound Registry and review of the literature. Endosc Ultrasound. 7:270–278. DOI: 10.4103/eus.eus_18_17. PMID: 28836514. PMCID: PMC6106155.
crossref
15. Matsushita M, Hajiro K, Okazaki K, Takakuwa H. 1999; Gastric aberrant pancreas: EUS analysis in comparison with the histology. Gastrointest Endosc. 49:493–497. DOI: 10.1016/S0016-5107(99)70049-0. PMID: 10202065.
crossref
16. Hase S, Nakazawa S, Yoshino J, et al. 1989; A study on gastric and small intestinal aberrant pancreas by endoscopic ultrasonography--with special reference to comparison with histological appearance. Nihon Shokakibyo Gakkai Zasshi. 86:1684–1691. PMID: 2685422.
17. Kida M, Kawaguchi Y, Miyata E, et al. 2017; Endoscopic ultrasonography diagnosis of subepithelial lesions. Dig Endosc. 29:431–443. DOI: 10.1111/den.12854. PMID: 28258621.
crossref
18. Yoshida T, Sakamoto A, Kuroki K, Kojo A, Watanabe H. 1976; Electrocoagulation biopsy of aberrant pancreas of the stomach. A case of aberrant gastric pancreas. Am J Gastroenterol. 66:554–558. PMID: 1020743.
19. Kojima T, Takahashi H, Parra-Blanco A, Kohsen K, Fujita R. 1999; Diagnosis of submucosal tumor of the upper GI tract by endoscopic resection. Gastrointest Endosc. 50:516–522. DOI: 10.1016/S0016-5107(99)70075-1. PMID: 10502173.
crossref
20. Lai EC, Tompkins RK. 1986; Heterotopic pancreas. Review of a 26 year experience. Am J Surg. 151:697–700. DOI: 10.1016/0002-9610(86)90045-0. PMID: 3717502.
21. Ormarsson OT, Gudmundsdottir I, Mårvik R. 2006; Diagnosis and treatment of gastric heterotopic pancreas. World J Surg. 30:1682–1689. DOI: 10.1007/s00268-005-0669-6. PMID: 16902740.
crossref
22. Khashab MA, Cummings OW, DeWitt JM. 2009; Ligation-assisted endoscopic mucosal resection of gastric heterotopic pancreas. World J Gastroenterol. 15:2805–2808. DOI: 10.3748/wjg.15.2805. PMID: 19522034. PMCID: PMC2695899.
crossref

FIGURES AND TABLES

Fig. 1
Flow chart of the study. SEL, subepithelial lesion.
KJG-76-009-f1.tif
Fig. 2
Endoscopic and EUS features of an ectopic pancreas. (A) Endoscopic appearance of an ectopic pancreas indicating Yamada type II polypoid lesion with central dimpling. (B) EUS image of the same lesion shown in Fig. 2A indicting that the SM (3rd) and PM (4th) layers are involved. EUS image showing a lesion of mixed echogenicity, heterogeneity, and indistinct border. The white arrows indicate anechoic duct-like structures. The star (*) represents the diameter of normal PM (PMnormal), and the rhombus represents the diameter of the lesion with PM thickening (PMep). In this case, PM thickening “PMep/PMnormal ≥2” was observed. (C) EUS image showing the presence of hyperechoic foci with acoustic shadowing suggesting central calcification. The black arrow indicates hyperechoic foci. (D) EUS image showing ectopic pancreas involving the MM (2nd) layer. Lesions with hyperechoic echogenicity, heterogeneity, and distinct border without PM thickening can be observed. (E) EUS image showing the ectopic pancreas involving the SM (3rd) layer. A lesion with hyperechoic echogenicity, heterogeneity, and an indistinct border with PM thickening “PMep/PMnormal ≥2; the rhombus represents the diameter of the lesion with PM thickening ((PMep). The star (*) represents diameter of normal PM (PMnormal). (F) EUS image showing ectopic pancreas involving the MM (2nd) layer. Lesions with hypoechoic echogenicity, heterogeneity, and distinct border without PM thickening are observed. (G) Histopathology findings of S-type ectopic pancreas. The biopsy specimen of the stomach showed a heterotopic pancreas composed of acinar cells (H&E, ×20). Heterotopic pancreatic tissue located in the submucosal layer. (H) Histopathology findings of D-type ectopic pancreas. Histopathology image showing pancreatic tissue composed of acinar cells and ductal elements located in the submucosal and subserosal layers of the stomach (H&E, ×20). EUS, endoscopic ultrasonography; SM, submucosa; PM, muscularis propria; MM, muscularis mucosa.
KJG-76-009-f2.tif
Fig. 3
Case of ESD of ectopic pancreas. (A) Endoscopic appearance of ectopic pancreas indicating Yamada type I polypoid lesion without central dimpling. (B) EUS finding of 10-mm sized ectopic pancreas involving the SM (3rd) layer. A lesion with mixed echogenicity, heterogeneity, and indistinct border without PM thickening is observed. (C) Endoscopic view of a submucosal dissection for an ectopic pancreas. (D) Removed ectopic pancreas specimen. Enucleation was performed. (E) Follow-up duodenoscopy after one month shows that the ulcer is healing after the endoscopic resection with a convergent fold without evidence of recurrence. EUS, endoscopic ultrasonography; SM, submucosa; PM, muscularis propria.
KJG-76-009-f3.tif
Table 1
Clinical Characteristics and Endoscopic and EUS Findings of 31 Patients with Gastric Ectopic Pancreas
Case Sex Age Location Umbilication Size(mm) Layer PMep/PMnormal Echogenicity Homogeneity Border Anechoic foci Calcification ESD or EMR EN bloc resection Complete resection
1 F 14 Antrum Yes 12 MM 1.29 Hypoechoic Homogeneous Indistinct No No EMR Yes No
2 F 34 Antrum Yes 10 MM, SM 1.33 Hypoechoic Homogeneous Distict No No ESD Yes Yes
3 M 26 Antrum Yes 10 SM, PM 5.27 Mixed Heterogeneous Indistinct No No ESD Yes Yes
4 M 27 Antrum No 10 MM, SM, PM 5.29 Hypoechoic Heterogeneous Indistinct No No ESD Yes Yes
5 F 44 Antrum No 14 MM, SM, PM 4.14 Mixed Heterogeneous Distict No No ESD Yes Yes
6 M 32 Antrum Yes 10 MM 1.2 Hypoechoic Heterogeneous Distict No No ESD Yes No
7 M 35 Antrum Yes 12 SM, PM 1.43 Mixed Heterogeneous Indistinct Yes No ESD Yes Yes
8 M 24 Antrum Yes 15 SM, PM 5.8 Mixed Homogeneous Indistinct No No ESD No No
9 F 27 Corpus Yes 15 SM, PM 3.18 Mixed Heterogeneous Indistinct Yes No ESD No No
10 M 40 Antrum No 13 MM 1.29 Mixed Heterogeneous Distict No No ESD Yes Yes
11 F 44 Antrum Yes 7 SM 4 Hypoechoic Homogeneous Indistinct No No ESD Yes Yes
12 F 39 Antrum Yes 10 SM, PM 5.28 Mixed Heterogeneous Indistinct Yes Yes ESD Yes Yes
13 F 52 Antrum No 10 SM 1.2 Mixed Heterogeneous Indistinct No No ESD Yes Yes
14 F 60 Antrum Yes 13 SM, PM 3.4 Mixed Heterogeneous Indistinct Yes No ESD Yes Yes
15 F 55 Antrum Yes 12 SM 1.24 Mixed Heterogeneous Distict No No ESD Yes Yes
16 M 43 Antrum Yes 8 MM, SM 1.06 Mixed Heterogeneous Distict No Yes ESD Yes Yes
17 F 36 Antrum No 8 MM 1.6 Mixed Homogeneous Distict No No EMR Yes Yes
18 F 47 Antrum No 10 MM, SM 1.68 Mixed Heterogeneous Indistinct No No EMR Yes No
19 M 40 Antrum No 12 SM 1.25 Hyperechoic Homogeneous Distict No No EMR Yes Yes
20 M 40 Antrum Yes 14 MM 1.1.4 Hyperechoic Heterogeneous Distict Yes No EMR Yes Yes
21 M 31 Antrum No 8 MM, SM, PM 3.59 Mixed Heterogeneous Indistinct Yes No EMR Yes No
22 F 30 Corpus Yes 15 SM 2.14 Hyperechoic Heterogeneous Indistinct Yes No EMR Yes Yes
23 M 24 Antrum No 7 MM 1.23 Mixed Heterogeneous Distict Yes No ESD No No
24 F 74 Corpus No 10 MM, SM 5.29 Mixed Heterogeneous Indistinct No Yes EMR Yes Yes
25 F 47 Antrum No 10 MM 2.29 Hyperechoic Heterogeneous Distict Yes No EMR Yes Yes
26 F 42 Antrum No 8 MM, SM 0.77 Mixed Homogeneous Indistinct No No EMR Yes Yes
27 M 67 Corpus No 9 MM, SM 0.94 Hypoechoic Heterogeneous Distict Yes No EMR No No
28 M 51 Corpus No 7 SM 1.67 Hypoechoic Heterogeneous Indistinct No No EMR Yes Yes
29 F 52 Antrum No 10 MM, SM 1.75 Hyperechoic Heterogeneous Indistinct No No EMR Yes No
30 F 57 Antrum No 8 SM 2.79 Mixed Heterogeneous Distict No No EMR Yes Yes
31 M 39 Antrum Yes 11 SM 1.81 Mixed Heterogeneous Distict No Yes ESD Yes Yes

EUS, endoscopic ultrasonography; PM, muscularis propria; PMep/PMnormal, ratio of PM thickening of the ectopic pancreas and normal mucosa; ESD, endoscopic subnormal dissection; EMR, endoscopic mucosal resection; F, female; MM. muscularis mucosa; SM, submucosa; M, male.

Table 2
EUS Features of Gastric Ectopic Pancreas
EUS feature Value
Mean size (mm) 10.6 (7.0-15.0)
Echogenicity
Hypoechoic 7 (22.6)
Hyperechoic 5 (16.1)
Mixed 19 (61.3)
Homogeneity
Homogeneous 7 (22.6)
Heterogeneous 24 (77.4)
Border
Distinct 14 (45.2)
Indistinct 17 (54.8)
Calcification
Yes 4 (12.9)
No 27 (87.1)
Anechoic ductal structure
Present 10 (32.3)
Absent 21 (67.7)
EUS classification
Superficial type 22 (71.0)
Deep type 9 (29.0)
Yamada classification
Type 1 12 (38.7)
Type 2 19 (61.3)
Central dimpling or umbilication
Yes 15 (48.4)
No 16 (51.6)
Mean PMep/PMnormal 2.46 (0.77-5.8)
PM thickening
Yes 13 (41.9)
No 18 (58.1)

Values are presented as mean (range) or number (%).

EUS, endoscopic ultrasonography; PM, muscularis propria; PMep/PMnormal, ratio of PM thickening of ectopic pancreas and normal mucosa.

Table 3
Clinical Outcome of an Endoscopic Resection of Ectopic Pancreas
Value
Procedure method
EMR 13 (41.9)
ESD 18 (58.1)
Mean procedure time
Total 36.2 (6-73)
EMR 24 (6-56)
ESD 44 (17-73)
En bloc resection
Total 27 (87.1)
EMR 12 (92.3)
ESD 15 (83.3)
Complete resection
Total 22 (71)
EMR 8 (61.5)
ESD 14 (77.8)
Adverse events
Immediate bleeding 5 (16.1)
Muscle defect 3 (9.7)
Perforation 0 (0.0)
Duration of follow up (months) 4.5 (1-18)
Residual lesion at follow up 0 (0.0)

Values are presented as mean (range) or number (%).

EMR, endoscopic mucosal resection; ESD, endoscopic submucosal dissection.

TOOLS
Similar articles